Population Pharmacokinetics of Indinavir in Patients Infected with Human Immunodeficiency Virus

Indinavir is currently used at a fixed dose of 800 mg either three times a day or twice a day in combination with 100 mg of ritonavir. Dosage individualization based on plasma concentration monitoring might, however, be indicated. This study aimed to assess the pharmacokinetic profile of indinavir i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Csajka, Chantal, Marzolini, Catia, Fattinger, Karin, Décosterd, Laurent A., Telenti, Amalio, Biollaz, Jérôme, Buclin, Thierry
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2004
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC514769/
https://ncbi.nlm.nih.gov/pubmed/15328077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.9.3226-3232.2004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars